Summary
The Norrbottnian type of Gaucher disease is characterized by infantile or juvenile onset and variable degrees of neurological symptoms, some of which develop only after splenectomy. A full neuropathological description of this type of Gaucher disease has not been reported previously. The brains of five patients were examined morphologically and biochemically. All presented typical accumulations of glucosylceramide storing cells in the adventitia of vessels in the cerebral and cerebellar sub-cortical white matter (s.c.w.m.). There were differences between the five cases with regard to the accumulation of adventitial storage cells and to the fatty acid pattern of the glucosylceramide isolated from the s.c.w.m., which implicate that the accumulation of glucosylceramide in adventitial cells in the brain is dependent on the generalized lipid storage process and enhanced by splenectomy. Loss of neurones and myelin was noted in the vicinity of accumulations of storage cells in two cases. The five cases whowed varying degrees of nerve cell loss, satellitosis and neuronophagia. Lipofuscin with simple and complex lipids but no glycolipids could be demonstrated in neurones light-microscopically. Utrastructural examination revealed inclusion bodies with bilayers in neurones of the cerebral and cerebellar cortex, dentate nucleus and pons. Because of the bilayered structure of Gaucher cell inclusions the bilayers in neurones are assumed to be formed by glucosylceramide. The fatty acid composition of glucosylceramide isolated from cerebral cortex in all cases suggested that cerebral gangliosides were its main precursor. The highest levels of psychosine (glucosylsphingosine) were seen in the cases with the most advanced nerve cell loss. The morphological and biochemical findings indicate that the neuronopathic process is associated with accumulation of glucosylceramide and psychosine in neurones.
Similar content being viewed by others
References
Adachi M, Wallace BJ, Schneck L, Volk BW (1967) Fine structure of central nervous system in early infantile Gaucher's disease. Arch Pathol 83:513–526
Adachi M, Volk BW (1977) Gaucher disease in mice induced by conduritol-B-epoxide; morphologic features. Arch Pathol 101:255–259
Adams CWM (1965) Neurohistochemistry. Elsevier, Amsterdam London New York
Bestetti G, Rossi GL (1980) The occurrence of cytoplasmic lamellar bodies in normal and pathologic conditions. Acta Neuropathol (Berl) 49:75–78
Blom S, Erikson A (1983) Gaucher disease — Norrbottnian type. Neurodevelopmental, neurological and neurophysiological aspects. Eur J Pediatr 140:316–322
Brady RO, Barranger JA (1983) Glucosylceramide lipidosis: Gaucher's disease. In: Stanbury JB, Wyngarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 842–856
Dreborg S, Erikson A, Hagberg B (1980) Gaucher disease — Norrbottnian type. I. General clinical description. Eur J Pediatr 133:107–118
Fewster ME, Burns BJ, Mead JE (1969) Quantitative densitometric thin-layer chromatography of lipids using copper acetate reagent. J Chromatogr 43:120–126
Fredrickson DS, Sloan HR (1972) Glucosylceramide lipidosis: Gaucher's disease. In: Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) The metabolic basis of inherited disease. McGraw Hill, New York, pp 730–759
Hansson H-A (1981) Lamellar bodies in Purkinje nerve cells experimentally induced by electric field. Brain Res 216:177–191
Kristensson K, Sourander P (1966) Occurrence of lipofuscin in inherited metabolic disorders affecting the nervous system. J Neurol Neurosurg Psychiatry 29:113–118
Lee RE, Worthington CR, Glew RH (1973) The bilayer nature of deposits occurring in Gaucher's disease. Arch Biochem Biophys 159:259–266
Lee RE (1982) The pathology of Gaucher disease. In: Desnick RJ, Gatt S, Grabowski GA (eds) Gaucher disease: a century of delineation and research. Liss, New York, pp 177–218
Maloney AFJ, Cumings JN (1960) A case of juvenile Gaucher's disease with intra-neuronal lipid storage. J Neurol Neurosurg Psychiatry 23:207–213
Månsson J-E, Vanier M-T, Svennerholm L (1978) Changes in fatty acid and sphingosine composition of the major gangliosides of human brain with age. J Neurochem 30:273–275
Nilsson O, Svennerholm L (1982) Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease. J Neurochem 39:709–718
Nilsson O, Månsson J-E, Håkansson G, Svennerholm L (1982a) The occurrence of psychosine and other glycolipids in spleen and liver from the three major types of Gaucher disease. Biochim Biophys Acta 712:453–463
Nilsson O, Håkansson G, Dreborg S, Groth CG, Svennerholm L (1982b) Increased cerebroside concentration in plasma and erythrocytes in Gaucher disease: Significant differences between Type I and Type III. Clin Genet 22:274–279
Norman RM (1970) Gaucher's disease. In: Vinken PZ, Bruyn GW (eds) Leucodystrophies and poliodystrophies. Handbook of clinical neurology, vol 10. North-Holland, Amsterdam, pp 509–531
Parkin JL, Brunning RD (1982) Pathology of the Gaucher cell. In: Desnick RJ, Gatt S, Grabowski GA (eds) Gaucher disease: a century of delineation and research. Liss, New York, pp 151–176
Saito T, Hakomori S-I (1971) Quantitative isolation of total glycosphingolipids from animal cells. J Lipid Res 12:257–258
Shiraki H, Okumura A, Oyanagi S (1977) Neuropathology of “Grumose degeneration” of the cerebellar dentate nucleus with special reference to certain neurotoxic disorders and other pathological processes. In: Roizin L, Shiraki H, Grcevic N (eds) Neurotoxicology. Raven Press, New York, pp 43–55
Sourander P, Conradi N, Nilsson O, Svennerholm L (1982) Brain and visceral pathology in Norrbottnian type of Gaucher's disease. IXth International Congress on Neuropathology, Vienna Austria
Sourander P, Conradi N (1983a) Neuronal changes in the Norrbottnian type of Gaucher's disease. Proceedings of a Joint Meeting of German and Scandinavian Neuropathologists, Turku. Acta Neurol Scand 68:190
Sourander P, Conradi NG (1983b) Neuropathology of Gaucher disease. International Symposium on Recent Progress in Neurolipidoses and Allied Disorders, Fondation Merieux. Lyon, May 31–June 2
Svennerholm L, Sourander P (1966) Investigations on brain autopsy material in lipidoses. Proceedings of the 5th International Congress of Neuropathology, Zürich 1965. Excerpta Medica Foundation, Amsterdam, p 342
Svennerholm L, Fredman P (1980) A procedure for the quantitative isolation of brain gangliosides. Biochim Biophys Acta 617:97–109
Svennerholm L, Dreborg S, Erikson A, Groth CG, Hillborg PO, Håkansson G, Nilsson O, Tibblin E (1982) Gaucher disease of the Norrbottnian type (type III). Phenotypic manifestations. In: Desnick RJ, Gatt S, Grabowski GA (eds) Gaucher disease: a century of delineation and research. Alan R Liss, New York pp 67–94
Winkelman MD, Banker BQ, Victor M, Moser HW (1983) Noninfantile neuronopathic Gaucher's disease: A clinicopathologic study. Neurology 33(8):994–1008
Author information
Authors and Affiliations
Additional information
Supported by grants from the Expressen's Prenatal Research Fund (Stockholm) and the Swedish Medical Research Council (proj. nos. 00627 and 6345)
Rights and permissions
About this article
Cite this article
Conradi, N.G., Sourander, P., Nilsson, O. et al. Neuropathology of the Norrbottnian type of Gaucher disease. Acta Neuropathol 65, 99–109 (1984). https://doi.org/10.1007/BF00690463
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00690463